These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18997163)

  • 1. Association of oral calcitriol with improved survival in non-dialysed and dialysed patients with CKD.
    Negri AL
    Nephrol Dial Transplant; 2009 Feb; 24(2):341-4. PubMed ID: 18997163
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of oral calcitriol with improved survival in nondialyzed CKD.
    Shoben AB; Rudser KD; de Boer IH; Young B; Kestenbaum B
    J Am Soc Nephrol; 2008 Aug; 19(8):1613-9. PubMed ID: 18463168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from geographic variations in predialysis nephrology care.
    Winkelmayer WC
    J Am Soc Nephrol; 2009 May; 20(5):930-2. PubMed ID: 19389840
    [No Abstract]   [Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active vitamin D and survival.
    Wolf M
    J Am Soc Nephrol; 2008 Aug; 19(8):1442-3. PubMed ID: 18614769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current status of renal replacement treatment in Cuba].
    Pérez-Oliva JF; Herrera R; Almaguer M; Pérez M; Mármol A
    Nefrologia; 2005; 25(6):721-2. PubMed ID: 16514917
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis In Myocardial Infarction (TIMI) risk score and mortality in patients with advanced chronic kidney disease and on dialysis.
    Baber U; Kini AS; Sharma SK; Kim MC; Farkouh ME; Muntner P
    Am J Cardiol; 2009 Jun; 103(11):1513-7. PubMed ID: 19463508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in chronic kidney disease: current data and nursing roles.
    Pearson MZ
    Nephrol Nurs J; 2008; 35(5):485-9. PubMed ID: 18856079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic on acute renal failure: long-term implications of severe acute kidney injury.
    Waikar SS; Winkelmayer WC
    JAMA; 2009 Sep; 302(11):1227-9. PubMed ID: 19755705
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients.
    Kovesdy CP
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):109-16. PubMed ID: 19233070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of ACE inhibitors and ARBs in severe chronic kidney disease: point-counterpoint.
    Creamer LM; Ryan J
    CANNT J; 2008; 18(4):46-8. PubMed ID: 19175194
    [No Abstract]   [Full Text] [Related]  

  • 12. Predicting outcomes in CKD: the importance of perspectives, populations and practices.
    Levin A
    Nephrol Dial Transplant; 2009 Jun; 24(6):1724-6. PubMed ID: 19264740
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitamin D and secreted Klotho: a long-awaited panacea for vascular calcification?
    Komaba H; Fukagawa M
    Kidney Int; 2012 Dec; 82(12):1248-50. PubMed ID: 23203019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents and emerging adults with chronic kidney disease: their unique morbidities and adherence issues.
    Diaz-Gonzalez de Ferris ME
    Blood Purif; 2011; 31(1-3):203-8. PubMed ID: 21228591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data.
    Vervloet MG; Twisk JW
    Nephrol Dial Transplant; 2009 Mar; 24(3):703-6. PubMed ID: 18768581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence in patients with chronic kidney disease.
    Raymond CB; Wazny LD; Sood AR
    CANNT J; 2011; 21(2):47-50; quiz 51-2. PubMed ID: 21894841
    [No Abstract]   [Full Text] [Related]  

  • 17. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E
    Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
    Ponte B; Bourquin V; Stoermann-Chopard C
    Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mortality associated with acute kidney injury requiring dialysis.
    Bihorac A; Schold JD; Hobson CE
    JAMA; 2010 Jan; 303(3):229; author reply 229-30. PubMed ID: 20085947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.